85273-96-7

Basic information

• Product Name: N,N-dimethyl-2-[(3-phenylquinolin-2-yl)sulfanyl]ethanamine hydrochloride (1:1)
• Synonyms: 2-(2-Dimethylaminoethylthio)-3-phenylquinoline hydrochloride;N,N-Dimethyl-2-((3-phenyl-2-quinolinyl)thio)ethanamine monohydrochloride;Ethanamine, N,N-dimethyl-2-((3-phenyl-2-quinolinyl)thio)-, monohydrochloride
• CAS NO: 85273-96-7
• Molecular Formula: C₁₉H₂₀N₂S*ClH
• Molecular Weight: 344.9014
• Mol File: 85273-96-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 452°C at 760 mmHg
• Flash Point: 227.1°C
• Vapor Pressure: 2.33E-08mmHg at 25°C
• CAS DataBase Reference: N,N-dimethyl-2-[(3-phenylquinolin-2-yl)sulfanyl]ethanamine hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-dimethyl-2-[(3-phenylquinolin-2-yl)sulfanyl]ethanamine hydrochloride (1:1)(85273-96-7)
• EPA Substance Registry System: N,N-dimethyl-2-[(3-phenylquinolin-2-yl)sulfanyl]ethanamine hydrochloride (1:1)(85273-96-7)

Safety Data

• Hazardous Substances Data: 85273-96-7(Hazardous Substances Data)

Upstream product

• 2859-30-5 2-chloro-3-phenyl-quinoline 
• 13242-44-9 2-(N,N-dimethylamino)ethylthiol hydrochloride 
• 85274-04-0 2-<<2-(N-methylamino)ethyl>thio>-3-phenylquinoline hydrochloride 
• 74-88-4 methyl iodide 

Relevant articles and documents

Quinoline derivatives which are 5-hydroxytryptamine antagonists

Compounds of the formula: STR1 wherein A stands for the radical --(CH2)2 -- which may bear one or two defined substituents; R1 stands for a (3-4C) alkyl or cyclopropyl radical, or a phenyl radical which may optionally bear one or two defined substituents, or a heteroaryl radical of five or six ring atoms which may optionally bear a (1-3C)alkyl substituent; R2 and R3 stand for hydrogen or a (1-2C)alkyl radical, or R2 stands for a (2-4C)alkylene radical which is linked to one of the carbon atoms forming the two-carbon-atom-backbone of A so as to form, together with the adjacent nitrogen atom, a pyrrolidinyl or piperidyl radical; and one of R4 and R5 stands for hydrogen, and the other stands for hydrogen, a halogen atom or a (1-3C)alkyl or (1-3C)alkoxy radical; and acid-addition salts thereof. Processes for the manufacture of said compounds. Pharmaceutical compositions comprising one of said compounds and a pharmaceutical diluent or carrier. The compounds are 5-hydroxytryptamine antagonists.